Hot Features
プレミアム
GW Pharm. (GWP)
LSE
BLACK FRIDAY
25周年を記念 1999-2024
Forexで最大60%オフ
1年間40％、2年間40％、*3年間60％
リアルタイム株価 | レベル2 | |
|---|---|---|
Forex |
*3年間で¥ 153396、たったの¥ 61358
ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
News) - GW Pharmaceuticals PLC Monday said it was focused on the approval of its flagship drug Epidiolex in childhood- ...
- Three Positive Phase 3 Epidiolex clinical trials reported in 2016 -- NDA submission and launch preparation on track -- Conference call today at 8:00 a.m. EST - LONDON, Dec. 05, 2016...
AIM 05 December 2016 NOTICE 05/12/2016 7:00am NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM GW PHARMACEUTICALS PLC At the request of the company trading on AIM for the under-mentioned...
GW Pharmaceuticals PLC 01 December 2016 GW Pharmaceuticals plc Announces Epidiolex(R) (cannabidiol) Data Presentations and Educational Programs at the American Society of Epilepsy Annual Meeting...
- Presentations include clinical results from Phase 3 programs in Lennox-Gastaut Syndrome and Dravet Syndrome, as well as additional independent reports from Epidiolex Expanded Access...
GW Pharmaceuticals PLC 30 November 2016 GW Pharmaceuticals to Report Q4 and Year-End Financial Results and Host Conference Call on 5 December, 2016 London, UK, 30 Nov 2016: GW Pharmaceuticals plc...
LONDON, Nov. 30, 2016 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and...
GW Pharmaceuticals PLC 24 November 2016 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 1. Identity of the issuer or GW Pharmaceuticals PLC the underlying issuer of existing shares to which...
LONDON, Nov. 22, 2016 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and...
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
02opida
1分前
02opida
1分前
02opida
1分前
02opida
2分前
02opida
2分前
02opida
2分前
02opida
2分前
02opida
2分前
weedtrader420
3分前
02opida
3分前
02opida
3分前
02opida
4分前
02opida
4分前
02opida
5分前
jimr1717
5分前
02opida
5分前
02opida
5分前
Real McCoy
6分前
Tadaaa
10分前
Penny2Dime
10分前
Penny2Dime
11分前
ElectricMountain53
12分前
NASDAQ2020
14分前
weedtrader420
14分前
weedtrader420
15分前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
